Cronos Group Inc (OTCMKTS:PRMCF) in a day when the market overall saw wild volatility, PRMCF had a banner day closing ahead +25%. One of the key catalysts for this cannabis company is its ability to tap into the global marketplace.

PRMCF is coming off the announcement that Cronos Australia will soon be live. This follows the announcement that the company’s Peace Naturals Project would be landing on shelves in Germany. The latter really brought a ton of momentum to PRMCF afetr its ACMPR license allowed it to tap into global markets. The company has made good on that license in short time.

Cronos Group Inc (OTCMKTS:PRMCF) trumpets itself as a principal investment firm operating in the Canadian cannabis space.

The firm seeks to invest in companies either licensed or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marihuana for Medical Purposes Regulations. The firm typically invests in companies based in Canada.

The firm is primarily an equity investor, may also advance debt as appropriate. It seeks to make minority investments with appropriate governance and shareholder rights. The firm seeks board representation consistent with the size of the investment but does not need control. Cronos Group was incorporated in January, 2013 and is based in Toronto, Canada.

According to company materials, “Cronos Group is a geographically diversified and vertically integrated cannabis company that operates two wholly-owned Licensed Producers (“LPs”) regulated within Health Canada’s Access to Cannabis for Medical Purposes Regulations (the “ACMPR”) and holds a portfolio of minority investments in other Licensed Producers. The Company’s flagship LPs, Peace Naturals Project Inc. (Ontario) and Original BC Ltd. (British Columbia), are collectively situated on over 125 acres of agricultural, licensed land. Cronos Group is focused on building an international iconic brand portfolio, providing patients with personalized care and creating value for our shareholders.”

Find out when $PRMCF stock reaches critical levels. Subscribe to Right Now by entering your Email in the box below.

“Cronos is focused on having a presence in all major international markets as the regulatory environment evolves. This Dealer’s License will enable us to expand the product offerings we export to these jurisdictions, which is instrumental to our global expansion strategy,” said Mike Gorenstein, CEO of Cronos.

Investors have witnessed the stock climb more than 200% in 3 months time and we are currently seeing 10-day volume cresting above 1M. PRMCF is one of the hottest stocks on the OTC and investors need to watch as it continues to approach an inflection point.

Furthermore, strengthening the financial side, PRMCF announced last month that it has closed its previously announced bought deal public offering, including the full exercise of the over-allotment option. According to the company’s release, a total of 5,257,143 common shares of PRMCF were sold at a price of $8.75 per Share for aggregate gross proceeds of approximately $46.0 million. This will provide the company with additional funding to continue to build toward its principal operating goals over the medium term.

Right now holding a capital value in the market of $890.02M, PRMCF has strong reserves in cash and seems to be increasing its revenue potential with recent moves. There is a lot of untapped potential in Australia and in Europe, PRMCF knows this and the race is on to attack those markets. We will be writing updates as more news shakes out. Sign-up for continuing coverage on shares of $PRMCF stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!

Disclosure: we hold no position in $PRMCF, either long or short, and we have not been compensated for this article.